- 中文名称
心钠肽前体Elisa试剂盒
- 英文名字
- NT-proANP ELISA Kit
- 供应商
- Biomedica Immunoassays
- 产品货号
- BI-20892
- 产品报价
- ¥12x8tests

- 产品说明书
- 点击查看
- 购买方式
- 90%产品中国有现货库存。银行转账、电汇、支票、现金,在线支付宝及网银支付,或直接与我们电话联系400-6800-868
- 产品新闻

- 背景资料
- N-terminal proatrial natriuretic peptide (NT-proANP 1-98) is the biologically inactive fragment (98 amino acid) of the ANP prohormone.
ANP is translated from its gene as a 151-amino acid precursor, pre-proANP. After removal of the 25-amino acid signal peptide, the tissue form of the hormone, a 126-amino acid proANP (γ-ANP) is generated. γ-ANP is proteolytically cleaved to the biologically active ANP (α-ANP) and to the 98 amino acid NT-proANP peptide (also known as proANP 1-98). The major molecular forms of circulating human ANP is thus the 28 amino-acid peptide (α-ANP) that contains a ring structure with a disulfide bridge and the 98-amino acid NT-proANP peptide, which is easier to detect in the circulation due to its longer half-life. Both peptides α-ANP and NT-proANP circulate in equimolar amounts.
ANP is secreted from the heart in response to atrial stretching or through stimulation by angiotensin II and endothelin. The most important stimulus for the release of the hormone into circulation is stretching of myocyte fibres. On release, the prohormone is split into equimolar amounts of the highly biologically active proANP (99-126), also known as -ANP or ANP, and the N-terminal part proANP (1-98) (also known as NT-proANP) (Nakagawa et al., 2019; Volpe et al., 2015).
NT-proANP is more stable and has a longer half-life (60-120 min) in circulation than ANP which is rapidly cleared from the circulation with a half-life of 3-4 minutes (Yandle et al., 1986). The natriuretic peptides have a common characteristic biochemical structure that consists of a ring of 17 amino acids and a disulfide bridge between 2 cysteine molecules (Clerico et al., 2011; Volpe et al., 2015; Yandle et al., 1986).
The ANP prohormone undergoes several cleavages to generate the biologically active form of the hormone. N-terminal (NT) prohormone fragments of natriuretic peptides are typically more stable, have longer half-lives, and circulate at higher concentrations compared to C-terminal biologically active hormone ends (Yandle et al., 1986). It has therefore been suggested that measuring NT prohormone fragments of ANP provide more accurate concentrations in samples (Clerico et al., 2011).
The expression and secretion of ANP increase significantly in pathological states accompanied by stretching the heart chambers, volume overload, and ischemic injury, such as heart failure and myocardial infarction.
- 产品描述
- Method
Sandwich ELISA, HRP/TMB, 12×8-well detachable strips
Sample type
Serum, EDTA plasma, citrate plasma, heparın plasma, urine, cell culture supernatant (in human, rat, mouse samples)
Sample volume
10 µl / well
Assay time
3 h / 30 min
Sensitivity
0.05 nmol/l (= 0.64 ng/ml)
Standard range
0 – 10 nmol/l (= 0 – 127 ng/ml)
Conversion factor
1 nmol/l = 12.7 ng/ml (MW: 12.7 kDa)
Precision
In-between-run (n=3): ≤ 9 % CV
Within-run (n=5): ≤ 5 % CV
Specificity
Endogenous and recombinant human NT-proANP (equivalent to proANP 1-98)
Very high sequence homology between human and rodent (rat, mouse) NT-proANP (the assay is suitable for rat and mouse samples)
Cross-reactivity
proANP (1-30) <1%, proANP (31-67) <1%, proANP (79-98) <1%, alpha ANP (99-126)<1%
proBNP (8-29) <1%, proBNP (32-57) <1%
proCNP (1-19) <1%, proCNP (30-50) <1%, proCNP (51-97) <1%
- 产品特点
- 保存建议
- +4°C
- 其他
- Biomedica Immunoassay(bmgrp)公司成立于1988年, 总部位于奥地利维也纳,主要致力于研究、开发和生产基于ELISA方法用于临床前研究相关标记物检测的工具。迄今为止Biomedica Immunoassay公司在心血管检测及骨代谢检测领域开发了一系列特色ELISA检测试剂盒,Biomedica Immunoassay的生产过程符合GMP/GLP指南,并符合ISO 9001:2015管理体系,有CE认证。Biomedica Immunoassay的产品根据FDA, EMEA和ICH指南进行验证,并具有验证报告。
-

- 注意
-
该页面的中文产品信息的翻译,仅供参考。准确的产品信息请以厂家的英文说明书为准。下单前,请浏览说明书确认。
-